Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma

Condition:   Hepatocellular Carcinoma, Radiotherapy, Sorafenib Intervention:   Radiation: concurrent sorafenib and IMRT, followed sorafenib maintenance Sponsor:   Chinese Academy of Medical Sciences Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials